SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Monsanto Co.
MTC 3.040-6.0%Jan 6 3:37 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dan Spillane who wrote (1486)3/4/1999 6:32:00 PM
From: nickscores   of 2539
 
The following is from The Street.Com Mailbag from just moments ago:

On the Mark with Monsanto

Jesse Eisinger: I used to be an equity research
associate following pharmaceuticals, and I thought
your article on Monsanto (MTC:NYSE) was
excellent. I think the stock has been supported
through the last couple years by merger rumors
and then solid expectations for MTC's drug
business (after the AHP merger fell thru). As a
result, the multiples have been high and it's been
harder for the stock to get a kick from Celebrex.
However, I also think that once EPS estimates are
actually increased based on hard historical data of
Celebrex's success (which hasn't yet happened),
the stock will start to move better. And any positive
news on any other relatively major drug in MTC's
pipeline (they still have a few) will also be a
stock-mover.

It is also true that Europeans are stonewalling
MTC. I believe it's a political thing. Why let an
American company control your agriculture?
However, it can't last forever. And the potential for
global warming, which could start to reduce crop
yields in as little as 10-20 years, also suggests
good long-term potential for the plant biotech
industry and MTC in particular.

-- Beth Lerner (received 3/4)
thestreet.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext